DZD6008: clinical trials recruiting now
4
Recruiting trials
3
Conditions studied
2
US states with sites
3
Countries
Phase breakdown
Phase 1 4
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer · DZD6008 for Lung cancer | 4 |
| Non Small Cell Lung Cancer · DZD6008 for Non Small Cell Lung Cancer | 3 |
| Nonsmall-cell Lung Cancer | 1 |
Recruiting trials involving DZD6008
- A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
- Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)
- DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)
- Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
Common questions
How many recruiting trials involve DZD6008?
4 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.